ARTICLE | Company News
Adherex, GlaxoSmithKline deal
January 22, 2007 8:00 AM UTC
AHX will pay GSK $1 million to acquire the pharma company's buy-back option to eniluracil. AHX licensed rights to the oral dihydropyrimidine dehydrogenase (DPD) inhibitor from GSK in 2005 (see BioCe...